Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Non-Current Deffered Revenue: 2009-2013

Historic Non-Current Deffered Revenue for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Sep 2013 value amounting to $136,000.

  • Avadel Pharmaceuticals' Non-Current Deffered Revenue was N/A to $136,000 in Q3 2013 from the same period last year, while for Sep 2013 it was $136,000, marking a year-over-year change of. This contributed to the annual value of $181,000 for FY2012, which is 88.18% down from last year.
  • As of Q3 2013, Avadel Pharmaceuticals' Non-Current Deffered Revenue stood at $136,000, which was up 61.90% from $84,000 recorded in Q2 2013.
  • Avadel Pharmaceuticals' Non-Current Deffered Revenue's 5-year high stood at $6.0 million during Q4 2009, with a 5-year trough of $84,000 in Q2 2013.
  • In the last 3 years, Avadel Pharmaceuticals' Non-Current Deffered Revenue had a median value of $1.3 million in 2012 and averaged $1.3 million.
  • Data for Avadel Pharmaceuticals' Non-Current Deffered Revenue shows a maximum YoY tumbled of 92.02% (in 2013) over the last 5 years.
  • Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Non-Current Deffered Revenue stood at $6.0 million in 2009, then slumped by 46.18% to $3.2 million in 2010, then tumbled by 52.85% to $1.5 million in 2011, then slumped by 88.18% to $181,000 in 2012, then plummeted by 92.02% to $136,000 in 2013.
  • Its Non-Current Deffered Revenue was $136,000 in Q3 2013, compared to $84,000 in Q2 2013 and $129,000 in Q1 2013.